Your browser doesn't support javascript.
loading
A randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder.
Bansal, Ravi; Hellerstein, David J; Sawardekar, Siddhant; Chen, Ying; Peterson, Bradley S.
Afiliação
  • Bansal R; Institute for the Developing Mind, Children's Hospital Los Angeles, CA 90027, USA; Department of Pediatrics, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90033, USA. Electronic address: rabansal@chla.usc.edu.
  • Hellerstein DJ; Depression Evaluation Service, Division of Clinical Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA.
  • Sawardekar S; Institute for the Developing Mind, Children's Hospital Los Angeles, CA 90027, USA.
  • Chen Y; Depression Evaluation Service, Division of Clinical Therapeutics, New York State Psychiatric Institute, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA.
  • Peterson BS; Institute for the Developing Mind, Children's Hospital Los Angeles, CA 90027, USA; Department of Psychiatry, Keck School of Medicine at the University of Southern California, Los Angeles, CA, USA 90033, USA.
Psychiatry Res Neuroimaging ; 331: 111634, 2023 06.
Article em En | MEDLINE | ID: mdl-36996664

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article